Glenview Trust’s VanEck Biotech ETF BBH Stock Holding History

Glenview Trust’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-9,300	Closed	-$1.65M	–	480
2024 Q3	$1.65M	Hold	9,300	–	–	0.03%	223
2024 Q2	$1.57M	Hold	9,300	–	–	0.03%	220
2024 Q1	$1.55M	Hold	9,300	–	–	0.03%	220
2023 Q4	$1.54M	Hold	9,300	–	–	0.04%	214
2023 Q3	$1.45M	Hold	9,300	–	–	0.04%	201
2023 Q2	$1.45M	Hold	9,300	–	–	0.04%	198
2023 Q1	$1.51M	Hold	9,300	–	–	0.05%	188
2022 Q4	$1.49M	Hold	9,300	–	–	0.05%	184
2022 Q3	$1.31M	Hold	9,300	–	–	0.05%	175
2022 Q2	$1.36M	Hold	9,300	–	–	0.05%	176
2022 Q1	$1.51M	Hold	9,300	–	–	0.05%	178
2021 Q4	$1.76M	Hold	9,300	–	–	0.06%	163
2021 Q3	$1.88M	Hold	9,300	–	–	0.07%	150
2021 Q2	$1.88M	Hold	9,300	–	–	0.07%	153
2021 Q1	$1.63M	Buy	+9,300	New	+$1.68M	0.07%	152

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Glenview Trust's BBH Position: Q4 2024 in Review

Glenview Trust sold out of VanEck Biotech ETF (BBH) in Q4 2024, closing a stake of 9,300 shares — an estimated $1.65M sold.

Glenview Trust first reported a position in BBH in Q1 2021 and held it in 15 quarters. The position peaked at $1.88M in Q3 2021. 115 funds tracked by Wall St. Rank hold BBH as of Q4 2024.

Glenview Trust reported no remaining VanEck Biotech ETF position as of Q4 2024 after selling out during the quarter.
Glenview Trust sold 9,300 VanEck Biotech ETF shares in Q4 2024, an estimated $1.65M.
Glenview Trust first reported a position in VanEck Biotech ETF in Q1 2021 and held it in 15 quarters.
Glenview Trust's VanEck Biotech ETF position peaked at $1.88M in Q3 2021.
115 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2024.

Based on Glenview Trust's 13F filing for Q4 2024, filed 10 Feb 2025.